إعلان
إعلان
ALZN
Alzamend Neuro, Inc. Common Stock
2.39
USDبرعاية
+0.05
+2.18%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
2.35
-0.04
-1.51%
تقارير أرباح ALZN
النسبة الإيجابية المفاجئة
ALZN تفوق 8 من 16 آخر التقديرات.
50%
التقرير التالي
بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q3 26 (Revenue/ EPS)
--
/-$2.10
التغير الضمني من Q2 26 (Revenue/ EPS)
--
/+600.00%
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+22.81%
Alzamend Neuro, Inc. Common Stock earnings per share and revenue
On ٠٩ ديسمبر ٢٠٢٥, ALZN reported earnings of -0.30 USD per share (EPS) for Q2 26, beating the estimate of -1.99 USD, resulting in a 84.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.46% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 المحللين forecast an EPS of -2.10 USD, with revenue projected to reach -- USD, implying an زيادة of 600.00% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Alzamend Neuro, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Alzamend Neuro, Inc. Common Stock reported EPS of -$0.30, beating estimates by 84.96%, and revenue of $0.00, 0% as expectations.
How did the market react to Alzamend Neuro, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -0.46%, changed from $2.17 before the earnings release to $2.16 the day after.
When is Alzamend Neuro, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
What are the forecasts for Alzamend Neuro, Inc. Common Stock's next earnings report?
Based on 4
المحللين, Alzamend Neuro, Inc. Common Stock is expected to report EPS of -$2.10 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان